Manulife (Manufacturers Life Insurance)
FULC icon

Manulife (Manufacturers Life Insurance)’s Fulcrum Therapeutics FULC Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.2K Buy
16,719
+617
+4% +$3.75K ﹤0.01% 2827
2026
Q1 		$124K Buy
16,102
+3,219
+25% +$29.9K ﹤0.01% 2576
2025
Q4 		$146K Sell
12,883
-1,065
-8% -$10.8K ﹤0.01% 2628
2025
Q3 		$128K Sell
13,948
-5,939
-30% -$43K ﹤0.01% 2719
2025
Q2 		$137K Sell
19,887
-2,524
-11% -$13.5K ﹤0.01% 2694
2025
Q1 		$64.5K Sell
22,411
-1,059
-5% -$3.89K ﹤0.01% 2794
2024
Q4 		$110K Sell
23,470
-304
-1% -$1.12K ﹤0.01% 2798
2024
Q3 		$84.9K Sell
23,774
-706
-3% -$5.24K ﹤0.01% 2902
2024
Q2 		$152K Buy
+24,480
New +$185K ﹤0.01% 2705
2023
Q2 		– Sell
-17,020
Closed -$48.5K – 3002
2023
Q1 		$48.5K Hold
17,020
– – ﹤0.01% 2863
2022
Q4 		$124K Buy
17,020
+2,009
+13% +$13.1K ﹤0.01% 2742
2022
Q3 		$121K Buy
15,011
+41
+0.3% +$294 ﹤0.01% 2755
2022
Q2 		$73.4K Buy
14,970
+3,398
+29% +$33.2K ﹤0.01% 2975
2022
Q1 		$274K Sell
11,572
-2,769
-19% -$39.2K ﹤0.01% 2569
2021
Q4 		$254 Buy
14,341
+334
+2% +$6.62K ﹤0.01% 2737
2021
Q3 		$395K Buy
+14,007
New +$265K ﹤0.01% 2459
2021
Q2 		– Sell
-11,460
Closed -$135K – 3239
2021
Q1 		$135K Buy
+11,460
New +$142K ﹤0.01% 3006

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FULC Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Fulcrum Therapeutics (FULC) stake by 3.8% in Q2 2026, buying an estimated $3.75K and bringing the position to 16,719 shares worth $61.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

Manulife (Manufacturers Life Insurance) first reported a position in FULC in Q1 2021 and has held it in 17 quarters since. The position peaked at $395K in Q3 2021. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 16,719 shares of Fulcrum Therapeutics worth $61.2K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 617 Fulcrum Therapeutics shares in Q2 2026, an estimated $3.75K.
  • Fulcrum Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2827 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Fulcrum Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Fulcrum Therapeutics position peaked at $395K in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.